This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
Prior Indications in the U.S.: To reduce the risk of myocardialinfarction, stroke, and unstable angina requiring hospitalization in adults with established cardiovascular disease.
It was compared with N-terminal pro–B-type natriuretic peptide (NT-proBNP), peak troponin T-us value GRACE (Global Registry of Acute Coronary Events), CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology and American Heart Association guidelines (..)
Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardialinfarction. Evidence for Wellens as a reperfusion syndrome To my knowledge, there is no research paper demonstrating this. Am Heart J. de Zwaan C et al.
Takotsubo is a sudden event, not one with crescendo angina. Such cases are classified as MINOCA (MyocardialInfarction with Non-Obstructed Coronary Arteries). Contemporary research studies of MINOCA have evaluated the prognosis of these patients, reporting a 12-month all-cause mortality of 4.7% (95% confidence interval, 2.6–6.9),
This is diagnostic of myocardialinfarction. She has done quite a bit of research on the topic. In middle age women, it accounts for 22-35% of all ACS presentations 1,3 , and the reported incidence of ST-elevation myocardialinfarction in this subset of patients is variable, but estimated to be between 24-50% 4.
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram.
The primary outcome was a composite of death from any cause, myocardialinfarction, or hospitalization for unstable angina at 2 years. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. The analysis composed of participants with multivessel or left main CAD.
The impact of this narrowing can ultimately result in angina (chest pain), which has been shown to double the risk of major cardiovascular events,1 as well as myocardialinfarction ( heart attack ) or even death. Use Heart to Act on Angina. Available at: [link]. Accessed May 2024.
In cardiovascular research, serotonin has been implicated in modulating vascular tone, platelet aggregation, and myocardial function. Further research is warranted to confirm these findings and to understand the underlying mechanisms. Circulation, Volume 150, Issue Suppl_1 , Page A4141170-A4141170, November 12, 2024.
Background Insights on the differences in clinical outcomes, quality of life (QoL) and health resource utilisation (HRU) with different levels of care available to post-acute myocardialinfarction (AMI) populations in rural and urban settings are limited. to 1.00, p=0.04); ERR=0.84 (95% CI, 0.78 to 0.92, p<0.001), respectively).
The patient was given aspirin, heparin, morphine, and ondansetron and and transferred to a PCI-capable facility for a diagnosis of "unstable angina" with dynamic ECG changes. AIVR is not always the result of significant pathology, but is classically associated with the reperfusion phase of acute myocardialinfarction.
Background In myocardialinfarction with nonobstructive coronary arteries (MINOCA), there are limited patient-level data on outcomes by sex and race. Methods Patients admitted to a single center with acute myocardialinfarction (MI) between 1 January 2012 and 31 December 2018, were identified by chart and angiographic review.
After percutaneous coronary intervention, DAPT was given for 1 month to patients presenting with stable angina. The primary end point was a composite of cardiac death, myocardialinfarction, or stent thrombosis up to 1 year (Academic Research Consortium definite and probable). presented with acute coronary syndrome; 33.7%
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardialinfarction (MI), stroke, and cardiovascular (CV) death.4 7 Research has shown inflammation plays a significant role in the development of atherosclerosis and ASCVD,8-10 and even the formation of plaque.11
EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardialinfarction (MI). The primary endpoint consisted of a composite of all-cause mortality, MI, stroke, coronary revascularization, or hospitalization for unstable angina. Here is our curated list of the top sessions.
In a study published by the American Heart Association, “Sex and Age Differences in the Association of Depression With Obstructive Coronary Artery Disease and Adverse Cardiovascular Events,” researchers investigated 3,237 patients (35% women) undergoing coronary angiography to evaluate for coronary artery disease (CAD).
There are only a few elite academic trialist groups capable of running large trials and there’s ample reason to be suspicious about the nexus that has developed between academia and the pharmaceutical companies that shower them with cash to hopefully get a positive study result and pay off the pharmaceutical research investment manifold.
Risk Factors for ED: Heart disease, specifically coronary artery disease (CAD) and acute myocardialinfarction (AMI), is closely linked to male erectile dysfunction. The aim is to restore proper blood flow to the heart, alleviating symptoms like chest pain (angina) and reducing the risk of heart attacks.
For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. However, it remains unclear whether these lower referral rates for women stem from physician bias, disparities in baseline clinical status, or differences in the extent of coronary artery disease. EuroIntervention.
However, the effects of both treatments on efficacy outcomes, including MACE, myocardialinfarction, angina, mortality, and thrombotic events, were similar.
CVD was defined as a self-reported physician's diagnosis of congestive heart failure, coronary heart disease, angina pectoris, myocardialinfarction, or stroke. The eGFR estimates were calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. ml/min/1.73 m².
As a result, the patient re-infarcted when that could easily have been prevented. Just look at all the research based on this ! How can any of that research be trusted when it classifies this as a success? How can we prevent the next re-infarction? Think of all the countless similar patients. Less than 1 in 15 in fact.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content